Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Real-Life and RCT Participants: Alendronate Users Versus FITs' Trial Eligibility Criterion.

Reyes C, Pottegård A, Schwarz P, Javaid MK, Van Staa TP, Cooper C, Diez-Perez A, Abrahamsen B, Prieto-Alhambra D.

Calcif Tissue Int. 2016 Apr 20. [Epub ahead of print]

PMID:
27099132
2.

Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: A population-based cohort study.

Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D.

Arthritis Rheumatol. 2016 Apr 5. doi: 10.1002/art.39707. [Epub ahead of print]

PMID:
27059260
3.

AI-related BMD variation in actual practice conditions: A prospective cohort study.

Rodríguez-Sanz M, Prieto-Alhambra D, Servitja S, Garcia-Giralt N, Garrigos L, Rodriguez-Morera J, Albanell J, Martínez-García M, González I, Diez-Perez A, Tusquets I, Nogués X.

Endocr Relat Cancer. 2016 Apr;23(4):303-12. doi: 10.1530/ERC-16-0025. Epub 2016 Feb 24.

PMID:
26911377
4.

HIV infection is associated with worse bone material properties, independently of bone mineral density.

Güerri-Fernández R, Molina D, Villar-García J, Prieto-Alhambra D, Mellibovsky L, Nogués X, González-Mena A, Guelar A, Trenchs-Rodríguez M, Herrera-Fernández S, Horcajada J, Díez-Pérez A, Knobel H.

J Acquir Immune Defic Syndr. 2016 Feb 19. [Epub ahead of print]

PMID:
26910501
5.

Patients With Atypical Femur Fractures Have the Same Mortality as the Background Population-Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications.

Abrahamsen B, Prieto-Alhambra D.

J Bone Miner Res. 2016 Mar;31(3):488-90. doi: 10.1002/jbmr.2801. Epub 2016 Feb 28. No abstract available.

PMID:
26840991
6.

Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study.

Hawley S, Javaid MK, Prieto-Alhambra D, Lippett J, Sheard S, Arden NK, Cooper C, Judge A; REFReSH study group.

Age Ageing. 2016 Mar;45(2):236-42. doi: 10.1093/ageing/afv204. Epub 2016 Jan 21.

7.

Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England.

Kendal AR, Prieto-Alhambra D, Arden NK, Carr A, Judge A.

Br J Sports Med. 2016 Feb;50(3):187. doi: 10.1136/bjsports-2014-f6549rep.

PMID:
26782767
8.

In response to Yang, Tuo et al. "Was the effect of obesity on the relative risk of replacement surgery in knee osteoarthritis patients overestimated?"

Leyland KM, Arden NK, Prieto-Alhambra D.

Arthritis Rheumatol. 2016 Jan 8. doi: 10.1002/art.39578. [Epub ahead of print] No abstract available.

PMID:
26748570
9.

Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis: A Prospective Cohort Study.

Leyland KM, Judge A, Javaid MK, Diez-Perez A, Carr A, Cooper C, Arden NK, Prieto-Alhambra D.

Arthritis Rheumatol. 2016 Apr;68(4):817-25. doi: 10.1002/art.39486.

PMID:
26556722
10.

Factors Associated with T2DM Treatment Choice Across Europe.

Overbeek JA, Heintjes EM, Hall GC, Lapi F, Prieto Alhambra D, Bezemer ID.

Value Health. 2015 Nov;18(7):A600. doi: 10.1016/j.jval.2015.09.2057. Epub 2015 Oct 20. No abstract available.

PMID:
26533368
11.

Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance.

Servitja S, Martos T, Rodriguez Sanz M, Garcia-Giralt N, Prieto-Alhambra D, Garrigos L, Nogues X, Tusquets I.

Ther Adv Med Oncol. 2015 Sep;7(5):291-6. doi: 10.1177/1758834015598536. Review.

12.

Impact of hip fracture on hospital care costs: a population-based study.

Leal J, Gray AM, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A; REFReSH study group.

Osteoporos Int. 2016 Feb;27(2):549-58. doi: 10.1007/s00198-015-3277-9. Epub 2015 Aug 19.

13.

Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom.

Judge A, Wallace G, Prieto-Alhambra D, Arden NK, Edwards CJ.

Rheumatology (Oxford). 2015 Dec;54(12):2244-8. doi: 10.1093/rheumatology/kev268. Epub 2015 Aug 4.

PMID:
26242858
14.

Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.

Carbonell-Abella C, Pages-Castella A, Javaid MK, Nogues X, Farmer AJ, Cooper C, Diez-Perez A, Prieto-Alhambra D.

Calcif Tissue Int. 2015 Dec;97(6):535-41. doi: 10.1007/s00223-015-0040-3. Epub 2015 Jul 23.

PMID:
26202819
15.

Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study.

Hawley S, Javaid MK, Rubin KH, Judge A, Arden NK, Vestergaard P, Eastell R, Diez-Perez A, Cooper C, Abrahamsen B, Prieto-Alhambra D.

J Bone Miner Res. 2016 Jan;31(1):234-44. doi: 10.1002/jbmr.2595.

PMID:
26174968
16.

CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.

Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués X.

J Mol Endocrinol. 2015 Aug;55(1):69-79. doi: 10.1530/JME-15-0079. Epub 2015 Jun 24.

PMID:
26108486
17.

Risks and Benefits of Bisphosphonate Therapies.

Reyes C, Hitz M, Prieto-Alhambra D, Abrahamsen B.

J Cell Biochem. 2016 Jan;117(1):20-8. doi: 10.1002/jcb.25266.

PMID:
26096687
18.

Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis.

Driessen JH, Henry RM, van Onzenoort HA, Lalmohamed A, Burden AM, Prieto-Alhambra D, Neef C, Leufkens HG, de Vries F.

Calcif Tissue Int. 2015 Aug;97(2):104-12. doi: 10.1007/s00223-015-9993-5. Epub 2015 Apr 17.

19.

Socio-economic status and the risk of developing hand, hip or knee osteoarthritis: a region-wide ecological study.

Reyes C, Garcia-Gil M, Elorza JM, Mendez-Boo L, Hermosilla E, Javaid MK, Cooper C, Diez-Perez A, Arden NK, Bolibar B, Ramos R, Prieto-Alhambra D.

Osteoarthritis Cartilage. 2015 Aug;23(8):1323-9. doi: 10.1016/j.joca.2015.03.020. Epub 2015 Mar 26.

PMID:
25819582
20.

Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis.

Mellibovsky L, Prieto-Alhambra D, Mellibovsky F, Güerri-Fernández R, Nogués X, Randall C, Hansma PK, Díez-Perez A.

J Bone Miner Res. 2015 Sep;30(9):1651-6. doi: 10.1002/jbmr.2497. Epub 2015 Jun 11.

PMID:
25736591
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk